Section Editors
- Steven Brandes, Washington university
- John Gearhart, Johns Hopkins Children's Center
- Debra E Irwin, University of North Carolina at Chapel Hill
- Ercan Kocakoc, Bezmialem Vakif University
- Salvatore Micali, University of Modena and Reggio Emilia
- Charles J Rosser, University of Florida
- Mostafa Taymour, University of Cairo
Executive Editor
- Hayley Henderson, BioMed Central
Editorial Board | Editorial Team | Instructions for authors | FAQ
Articles
-
BMC Urology 2011, 11:19p21 upregulation in urothelial carcinoma cells
The phosphatidylinositol 3'-kinase (PI3K) growth factor signaling pathway upregulates p21 by suppressing glycogen synthase kinase-3 beta activity and activating mTOR in both cultured human urothelial carcinoma cells and mouse urothelial cells in vivo.
Hot topic
BMC Urology 2012, 12:2 (10 January 2012)
Scope
BMC Urology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of urological disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
From the blog
- 30 January 2012
- BMC-series journals on track for Impact Factor
- 18 January 2012
- Bacterial symbionts – the key to fighting pests and diseases?
- 10 January 2012
- BMC Ecology starts 2012 on a high!
Quote
"I strongly believe in the internet and open-access publishing in order to achieve scientific outreach both within academia and outside academia. Open-access allows anyone in the world with access to a computer to access scientific research. These innovative journals are becoming extremely successful and will change the nature of scientific publishing and increase the accessibility of science."
Professor Sally Blower
Semel Institute for Neuroscience & Human Behavior,
UCLA David Geffen School of Medicine, USA
News from the web
Email alerts
Receive periodic news and updates relating to BioMed Central.
RSS
Comments
View more comments